Zobrazeno 1 - 10
of 38
pro vyhledávání: '"G. M. Mullen"'
Autor:
D. H. Silber, Murad Alam, David S. Feldman, G. M. Mullen, R. M. Oren, Robert N. Brown, Clyde W. Yancy
Publikováno v:
American Journal of Transplantation. 11:1488-1497
Skin cancer incidence has been shown to be increased in the context of transplant-associated immunosuppression. There is, however, limited information specifically about the incidence of skin cancer after cardiac transplantation in the United States.
Publikováno v:
Blood. 86:3333-3340
Posttransplant lymphoproliferative disorder (PTLD) is a frequently fatal complication of organ transplantation, occurring in 2% to 6% of cardiac recipients. Treatment remains poorly defined. Reduction in immunosuppression is effective in a proportion
Autor:
W. G. Kao, Daniel L. McGee, Maria Rosa Costanzo, Alain Heroux, M. R. Johnson, Youlian Liao, G. M. Mullen
Publikováno v:
Journal of the American College of Cardiology. 24:1547-1551
Objectives . This study compared the survival of patients with heart failure who have waited > 6 months for heart transplantation with that of patients who undergo heart transplantation after a similarly prolonged waiting period. Background . There a
Autor:
Y. Khatib, W. G. Kao, Ching-Tung Lung, Maria Rosa Costanzo, M. R. Johnson, J. J. Glazier, A. I. Heroux, G. M. Mullen, S. G. Fisher, D. Koch
Publikováno v:
Clinical Cardiology. 17:489-494
The purpose of this study was to determine factors associated with the development of a persistently depressed cardiac output during the first year after cardiac transplantation. With this aim in mind, the records of 133 consecutive patients undergoi
Autor:
J E Balhan, P Silverman, Alain Heroux, G M Mullen, M. R. Costanzo, Youlian Liao, T L McKiernan, Fred Leya, M R Johnson, O'Sullivan Ej
Publikováno v:
Circulation. 89:272-277
BACKGROUND The diffuse nature of cardiac allograft vasculopathy makes early detection of the disease by traditional noninvasive methods or coronary angiography difficult. The aim of this study was to determine if there is a relation between abnormali
Autor:
G. M. Mullen, Maryl R. Johnson, E. A. Hubbell, Kao W, E J O'Sullivan, Roque Pifarre, Bruce M. McManus, Costanzo-Nordin Mr, John A. Robinson, Alain Heroux
Publikováno v:
Transplantation. 53:808-814
Photopheresis is a potential therapy for rejection in which reinfusion of mononuclear cells exposed to ultraviolet-A light ex vivo, after treatment with 8-methoxypsoralen in vivo, initiates host immune responses that specifically inhibit the cytotoxi
Autor:
Barbara A. Pisani, John A. Robinson, William O. Howe, K. Malinowska, G. M. Mullen, Jose C. Mendez, Robert C. Lichtenberg
Publikováno v:
Journal of the American College of Cardiology. 41(6)
Autor:
D. Pitts, Guillermo Cintron, David C. Naftel, Cindi Thomas, J.A. O'Donnell, G. M. Mullen, Branislav Radovancevic, Jon A. Kobashigawa, Robert C. Bourge, David C. McGiffin
Publikováno v:
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 20(2)
Autor:
Barbara A. Pisani, Bryan K. Foy, John A. Robinson, J.A. Mendez, K. Malinowska, G. M. Mullen, J. Maly, M. Stout, A.P. Broussard, Linda Dusek
Publikováno v:
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 20(2)
Autor:
Robert C Lichtenberg, Marc A. Silver, P.C. Barath, C.E Lawless, John A. Robinson, Vijay Yeldandi, G. M. Mullen, P. J. O'Keefe, K. Malinowska
Publikováno v:
Transplantation proceedings. 30(8)
The presented data show the combined sequential use of i.v. G for 14 days followed by PO G for 90 days is a much more effective prophylaxis for CMVD after heart transplantation than use of i.v. G for 14 days followed by PO A for 90 days. A need for h